Skip to content

Cardinal Health CAH Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

AbbVie logo
AbbVieABBV
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.64B+41.6%
Enterprise value$60.62B+34.8%
P/E35.8×+10.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's indefinite- lived intangible impairment?
Cardinal Health (CAH) reported indefinite- lived intangible impairment of $6.38B in Q1 2026.
How has Cardinal Health's indefinite- lived intangible impairment changed year-over-year?
Cardinal Health's indefinite- lived intangible impairment increased by 8.9% year-over-year, from $5.86B to $6.38B.
What is the long-term trend for Cardinal Health's indefinite- lived intangible impairment?
Over 4 years (2021 to 2025), Cardinal Health's indefinite- lived intangible impairment has grown at a 6.5% compound annual growth rate (CAGR), from $4.93B to $6.33B.